CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Healthcare$0.27-3.30%ClosedMarket Cap: $5.8M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.00
P/S
148.17
EV/EBITDA
-1.04
DCF Value
$0.01
FCF Yield
-124.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1.3%
Operating Margin
-9154.6%
Net Margin
-9366.8%
ROE
-1569.1%
ROA
-55.0%
ROIC
-82.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| FY null | $49.9K | $-4.7M | $— |
| FY null | $48.3K | $-1.6M | $— |
| FY null | $100.8K | $-1.1M | $— |
| FY null | $56.6K | $-1.1M | $— |
Trading Activity
Insider Trades
View AllTEO Peng Kwangdirector, 10 percent owner:
SellTue Apr 21
RAINA Natasha Kaurdirector:
SellTue Apr 21
QUEK David Yong Qidirector, 10 percent owner, officer: Chief Executive Officer
SellTue Apr 21
LEE Jimmy Peng Siewdirector, 10 percent owner:
SellTue Apr 21
KOH Pee Keatdirector:
SellTue Apr 21
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
SG
Exchange
—
Beta
1.93
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.